Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model

Hernandez-Boluda, JC; Pereira, A; Alvarez-Larran, A; Martin, AA; Benzaquen, A; Aguirre, L; Mora, E; Gonzalez, P; Mora, J; Dorado, N; Sampol, A; Garcia-Gutierrez, V; Lopez-Godino, O; Fox, ML; Reguera, JL; Perez-Encinas, M; Pascual, MJ; Xicoy, B; Parody, R;...

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

Builes, MM; Cuenca, MV; Soler, JLF; Astigarraga, I; Martinez, AP; Valero, JMV; Tong, HY; Quiroga, JV; Casanova, LF; Lopez, AE; Sisinni, L; Blanquer, M; Aguilar, IM; Martinez, BG; Borobia, AM; Perez-Martinez, A – 2020

Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

Penack, O; Peczynski, C; van der Werf, S; Finke, J; Ganser, A; Schoemans, H; Pavlu, J; Niittyvuopio, R; Schroyens, W; Kaynar, L; Blau, IW; van der Velden, WJFM; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Pascual-Cascon, MJ; Moreira, MC;...